NCT06560294View on ClinicalTrials.gov

Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 17, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Glue EmbolizationPelvic Congestion Syndrome
Interventions
DRUG

Micronized purified flavonoid fraction (Daflon ®)

Patients will receive micronized purified flavonoid fraction (Daflon ®), 500 mg twice/daily for 3 months.

OTHER

Glue embolization

Patients will receive transcatheter glue embolization.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER